Causal approaches based on the potential outcome framework provide a useful tool for addressing noncompliance problems in randomized trials. We propose a new estimator of causal treatment effects in randomized clinical trials with noncompliance. We use the empirical likelihood approach to construct a profile random sieve likelihood and take into account the mixture structure in outcome distributions, so that our estimator is robust to parametric distribution assumptions and provides substantial finite-sample efficiency gains over the standard instrumental variable estimator. Our estimator is asymptotically equivalent to the standard instrumental variable estimator, and it can be applied to outcome variables with a continuous, ordinal or binary scale. We apply our method to data from a randomized trial of an intervention to improve the treatment of depression among depressed elderly patients in primary care practices.
INTRODUCTION
When there is noncompliance in randomized trials, there is often interest in estimating the causal effect of actually receiving the treatment compared to receiving the control. Knowledge of this effect is useful for predicting the impact of the treatment in a setting for which compliance let Y r * ,a * * be the vector of potential outcomes under randomization assignment r * and treatments received a * , with individual element Y r * ,a * i being the potential outcome for subject i with the vectors of randomization assignments r * and treatments received a * . The sets of {Y r * ,a * i | r * ∈ {0, 1} N , a * ∈ {0, 1} N } and {A r * i | r * ∈ {0, 1} N } are 'potential' outcomes and treatments received in the sense that we can only observe one member of each set. The observed outcome and treatment received variables for subject i are Y 
2·2. Instrumental variable assumptions
We make similar assumptions to those in Angrist et al. (1996) . Assumption 1. Stable unit treatment value assumption (Rubin, 1980) Assumption 2. Random assignment. This assumption implies independence between assignment and pretreatment variables including potential outcomes and treatment receiveds.
Assumption 3. Random sampling. We assume that the N subjects in the trial are independent and identically distributed draws from a superpopulation; that is, Y r,a i and A r i (i = 1, . . . , N ), are independent and identically distributed with the same distribution as the random vector consisting of Y r,a and A r .
Assumption 4. Mean exclusion restriction. We assume that E(Y r,a ) = E(Y r
a ) for all r, r , a; that is, the randomization assignment affects the mean of the observed outcome only through its effect on treatment received. The mean exclusion restriction is weaker than the unit-level exclusion restriction of Angrist et al. (1996) , who assume that Y r,a i = Y r ,a i for all r, r , a. However, we believe that in most applications in which the weaker mean exclusion restriction is plausible, the stronger unit-level exclusion restriction is also plausible; we primarily use the weaker mean exclusion restriction because it is easier to work with this assumption.
Assumption 5. Nonzero average causal effect of R on A.
Assumption 6. Monotonicity. We assume that pr(A 1 A 0 ) = 1, so no one would receive the opposite treatment of his or her assignment under both assignment to treatment and to control.
2·3. Compliance classes
A subject in a two-arm trial can be classified into one of four compliance classes: In practice, we can observe only one of A 0 i and A 1 i , so that a subject's compliance status is not observed directly in a trial, but it can be partially identified based on treatment assignment and the observed treatment received; see Table 1 . The monotonicity assumption rules out the existence of defiers; see Table 2 . For single consent design trials (Zelen, 1979) , which have the property that the control group cannot access the treatment, that is, pr(A 0 = 0) = 1, the presence of always-takers and defiers is ruled out; see Table 3 . 2·4. Major established estimators Under Assumptions 1-6, the compliers are the only subgroup for which a randomized trial provides information about the causal effect of receiving treatment (Angrist et al., 1996) . For always-takers and never-takers, assignment to treatment has no effect on treatment received. The complier average causal effect, E(Y 1 − Y 0 | C = 1), can be regarded as the causal effect of receiving treatment for the subpopulation of compliers because, for compliers, assignment of treatment agrees with receipt of treatment. Angrist et al. (1996) show that, under Assumptions 1-6, the complier average causal effect is
which is the intention-to-treat effect divided by the proportion of compliers. The standard instrumental variable estimator is the sample analogue of (1),
where theÊs denote sample means; expression (2) is sometimes called the Wald estimator. The standard instrumental variable estimator does not take full advantage of the mixture structure of the outcomes of the four observed groups in Table 1 , as we will discuss in § 3·1. Imbens & Rubin (1997a , 1997b present two approaches using mixture modelling to estimate the complier average causal effect. One approach assumes a parametric distribution, such as normal, for the outcomes for each compliance class group under each randomization assignment. The complier average causal effect is then estimated by maximum likelihood for this model using the EM algorithm. This estimator provides considerable efficiency gains over the standard instrumental variable estimator when the parametric assumptions hold; see Table 4 . However, when the parametric assumptions are wrong, this estimator can be inconsistent whereas the standard instrumental variable estimator is consistent; see Table 4 for finite-sample results.
Imbens and Rubin's other approach to using mixture modelling to estimate the complier average causal effect is to approximate the density of the outcome distribution for each compliance class under each randomization group as a piecewise constant function, and then estimate the complier average causal effect by maximum likelihood. This approach is in principle nonparametric as the number of constant pieces in each density function can be increased with the sample size. However, Imbens & Rubin (1997b) do not provide a systematic approach for choosing the number of and locations of the pieces. We develop a systematic, easily implementable approach for doing this using empirical likelihood in the next section.
ESTIMATION THROUGH EMPIRICAL LIKELIHOOD APPROACH

3·1. Motivation and description of empirical likelihood approach
We first motivate and describe our method for single consent design trials, where the presence of always-takers and defiers is ruled out. Table 3 shows the relationship between observed (R, A) groups and latent compliance classes for a single consent design trial. The complier average causal effect can be re-expressed under Assumptions 1-6 as
where μ c1 , μ c0 , μ n and μ R=0 denote the mean potential outcomes of the compliers under treatment, compliers under control, never-takers and the whole population of subjects when assigned to the control, respectively; and π c denotes the proportion of compliers. The standard instrumental variable estimator estimates the complier average causal effect by substituting 24 J. CHENG ET AL.
the method of moments estimates from the sample for
. However, as noted by Imbens & Rubin (1997b) , there are restrictions on the joint density of (Y, R, A) that are not taken into account by the method of moments but which can be useful for estimating E(Y | R = 0), pr(A = 1 | R = 1) and E(Y | R = 1, A = 0). To be specific, Assumptions 1-6 imply the following restrictions. Supplementing a sample from a distribution that is a mixture of two components with samples from one or both of the components alone provides additional information for estimating aspects of the mixture distribution; see for example Hall & Titterington (1984) , Lancaster & Imbens (1996) and Qin (1999) . Here, the sample of Y 1 , . . . , Y N for which R i = 1, A i = 0 provides information about the never-taker component of the mixture Y | R = 0 and the sample of A 1 , . . . , A N for which R i = 1 provides information about the mixing proportion in the mixture Y | R = 0. We now illustrate how this information is useful in a setting with a binary outcome in which
The following is a plausible sample in this setting, with # meaning 'the number of ':
the p-value for a χ 2 test of whether or not this sample comes from the distribution (4) is 0·37. For this sample, the method of moments estimates of the quantities in (3), namelyÊ(
Restrictions 1-3. Figure 1 plots the profile loglikelihood for this sample under the probability model given by Assumptions 1-6 with binary outcomes. The maximum likelihood estimator of CACE, which takes into account the mixture structure of the outcomes given by Restrictions 1-3, has a noticeably higher likelihood than the standard instrumental variable estimator, which ignores some of the restrictions. The maximum likelihood estimator's property of taking into full account the mixture structure leads to substantially better estimates; in 1000 simulations from model (4), the mean squared error of the maximum likelihood estimator was 0·048 compared to 0·156 for the standard instrumental variable estimator.
To take account of the mixture structure of the outcomes given by Restrictions 1-3 for more general distributions of outcomes in a nonparametric way, we use the empirical likelihood approach. The empirical likelihood for a parameter such as the complier average causal effect is the nonparametric profile likelihood for the parameter. Maximum empirical likelihood estimators have good properties for a wide class of semiparametric problems; see Owen (2001) and Qin & Lawless (1994) for discussion. Without loss of generality, we arrange the subjects so that R 1 = · · · = R n 0 = 0 and
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Throughout our paper, we will follow (Owen, 2001, § 2·3) (6)- (9) represent the population probabilities that a complier assigned to the control and a never-taker assigned to the control have the same outcome as subject i, respectively. The conditions (6)-(9) involving the p c0 i and p n i encode the restrictions on the distribution of Y | R = 0 that come from it being a mixture of the compliers and never-takers under Assumptions 1-6; see Restrictions 1-3. The maximum empirical likelihood estimate of
To ease the computational burden of computing the maximum empirical likelihood estimate, we do not maximize over μ n , but instead use the method of moments
In model (4), this approximate maximum empirical likelihood estimator of the complier average causal effect performed almost as well as the maximum empirical likelihood estimator; its mean squared error was 0·051 compared to 0·048 for the maximum empirical likelihood estimator.
3·2. Computation for empirical likelihood approach
To find the approximate maximum empirical likelihood estimate, we conduct a grid search over
) over a grid ofπ c from 0 to 1. As we will see below,
does not depend on μ c1 , so finding the maximizing μ c1 and μ c0 can be done separately. To find the maximizing μ c1 , we note that arg max
By multiplying the q i s by 1/π c , we see that finding arg max μ c1 L E (π c ,μ n , μ c1 , μ c0 ) is equivalent to finding the maximum empirical likelihood estimator of the mean of the popula-
where we use the fact that, for the μ c0 that satisfies (6)- (8) with μ n =μ n , π c =π c . Finding the maximum likelihood estimate directly is challenging because of the complex parameter restrictions in (6)-(8). However, consider using the EM algorithm, where we regard each subject's compliance class as 'missing data'. We can re-express the observed data likelihood (i = 1, . . . , n 0 ) , and instead we maximize over a single variable. The tractability of both the E and M steps makes the EM algorithm with each subject's compliance class as missing data easy to use for finding q * 1 , . . . , q * n 0 and hence finding arg max μ c0 L E (π c ,μ n , μ c1 , μ c0 ) by (10).
Nonparametric estimation of causal effects
Given q i (i = 1, . . . , n 0 ), there are typically more than one set of p The proof of Lemma 1 is outlined in Appendix B. In summary, we estimate π c , μ n , μ c1 , μ c0 as follows; a program is available from the authors.
Step 1. We obtainμ n as the sample mean of Y | R = 1, A = 0.
Step 2. We obtainμ c1 as the sample mean of Y | R = 1, A = 1.
Step 3. For a grid ofπ c , we find the maximum empirical likelihood estimate of μ c0 given π c =π c , μ n =μ n , μ c1 =μ c1 using the EM algorithm described above.
Step 4. Our approximate maximum empirical likelihood estimate of the complier average causal effect isĈACE A =μ c1 −μ c0 .
3·3. Estimation in trials where the assigned-to-control group can access treatment
Our method illustrated in § 3·1 can be directly applied to more general trials under Assumptions 1-6 in which the control group can access the treatment. For such trials, we have one more compliance class, the always-takers, in addition to the compliers and never-takers; see Table 2 . We denote the proportion of always takers and the mean of always takers' potential outcomes by π a and μ a , respectively. The empirical likelihood L E of the parameters (π c , π a , μ n , μ a , μ c1 , μ c0 ) is the maximized likelihood for multinomial distributions (q 1 , . . . , A N ) that are consistent with (π c , π a , μ n , μ a , μ c1 , μ c0 ) and the restrictions on the parameter space specified by Assumptions 1-6, namely
As with the single consent design, rather than finding the maximum empirical likelihood estimate of (π c , π a , μ n , μ a , μ c1 , μ c0 ), we find the approximate maximum empirical likelihood estimate by setting μ n equal to the sample mean of Y | R = 1, A = 0, corresponding to the known never-takers in the sample, and μ a equal to the sample mean of Y | R = 0, A = 1, corresponding to the known always-takers in the sample, and then maximizing (π c , π a , μ c1 , μ c0 ). This can be done by using the EM algorithm for estimating μ c0 in the Y | R = 0, A = 0 sample as in § 3·2, and an analogous EM algorithm for estimating μ c1 in the Y | R = 1, A = 1 sample. The details are provided in a technical report available from the authors.
SIMULATION STUDIES
We compare our approximate maximum empirical likelihood estimator with the standard instrumental variable estimator and Imbens and Rubin's parametric estimator, considering single consent design trials as discussed in § 3·1. We set π c = 0·5 and compare the three estimators under different outcome distributions and under sample sizes of N = 100 and N = 500 with pr(R = 1) = 0·5. The outcome distributions we consider are Normal, gamma, and lognormal distributions. For each outcome distribution, we set μ c1 = 2, μ c0 = 1, so that the CACE = μ c1 − μ c0 = 1. The variances are fixed at 1.
Before explaining our settings for μ n , we discuss the impact of the distance between μ n and μ c0 on the efficiency of the approximate maximum empirical likelihood estimator relative to the standard instrumental variable estimator. The distance between μ n and μ c0 is a measure of the separation between the distributions of the compliers and never-takers under the control. To see the impact of the distance between μ n and μ c0 , we consider under what conditions the approximate maximum empirical likelihood and standard instrumental variable estimators are equal. The standard instrumental variable estimator estimates the complier average causal effect by substituting method of moments estimates into (3). The approximate maximum empirical likelihood estimator estimates the complier average causal effect by substituting maximum empirical likelihood estimates into (3) conditional on E(Y | R = 1, A = 0) being set equal to its method of moments estimate. The approximate maximum empirical likelihood estimator equals the standard instrumental variable estimator if the method of moments estimates of pr(A = 1 | R = 1) and E(Y | R = 1, A = 0), denoted bypr(A = 1 | R = 1) andμ n , respectively, satisfy (6)-(8) with q i = 1/n 0 for i = 1, . . . , n 0 . This will happen if and only ifμ n is between the trimmed mean of Y | R = 0 over the 0 to {1 −pr(A = 1 | R = 1)} quantiles and the trimmed mean of Y | R = 0 over thepr(A = 1 | R = 1) to 1 quantiles. It is more likely thatμ n will escape these bounds when the distributions of the compliers and the never-takers are more separated. When μ n does escape these bounds, we expect that the approximate maximum empirical likelihood estimator will provide a better estimate than the standard instrumental variable estimator because the former takes better account of the mixture structure of outcomes implied by Assumptions 1-6. Thus, we expect that the approximate maximum empirical likelihood estimator will gain more efficiency over the standard instrumental variable estimator when the distance between μ n and μ c0 is greater, because then the distributions of the compliers and never-takers under the control are more separated.
To see the effect of the separation between the compliers and never-takers under the control, we chose two sets of values for μ c0 and μ n such that the distributions of the compliers and never-takers under the control are well separated under one set of values but are close to each other under another set of values. In setting N 1 , the distributions of Y For each setting, we present summary results over 1000 replications with sample sizes of 100 and 500. Table 4 , which gives the bias and mean squared error from the three different estimators at Rutgers University on July 2, 2013 http://biomet.oxfordjournals.org/ Downloaded from for the complier average causal effect for the different settings considered, shows the following features.
First, the parametric estimator based on the normality assumption is unbiased and more efficient than the standard instrumental variable and approximate maximum empirical likelihood estimators under the true normal distributions, but shows biases of 23-40% and is less efficient than the other two estimators under nonnormal distributions.
Second, both the approximate maximum empirical likelihood and standard instrumental variable estimators have low bias for all settings considered. The approximate maximum empirical likelihood estimator has bias below 5% when the distributions of the never-takers and the compliers under the control are close to each other. When the distributions of the never-takers and compliers under the control are well separated and the sample size is 100, the approximate maximum empirical likelihood estimator has a bias of about 10% but this bias drops to below 5% when the sample size increases to 500.
Third, the approximate maximum empirical likelihood estimator is more efficient than the standard instrumental variable estimator for all settings considered. The gain in mean squared error is more substantial when the distributions of never-takers and compliers under the control are well separated, as expected from the discussion above. The gain in mean squared error is as large as 56%. The gain is generally smaller with a sample size of 500 rather than 100. In additional simulations not presented, we found that there is still a gain in mean squared error for the approximate maximum likelihood estimator with a sample size of 1000.
We also did a simulation study for the setting of § 3·3 in which the assigned-to-control group can access the treatment. The results are not presented, but are available from the authors. The pattern of results is similar to that for the single consent design trials.
ASYMPTOTIC PROPERTIES
In § 4, we showed that the approximate maximum empirical likelihood estimator gains over the standard instrumental variable estimator in a range of finite-sample situations, with larger gains when the compliers and never-takers' outcome distributions under the control are more separated. The standard instrumental variable estimator is based on estimating the distribution of (Y, A, R) by the empirical distribution of (Y, A, R); the method of moments estimators on which the standard instrumental variable estimator is based are the moments of the empirical distribution. The source of the approximate maximum empirical likelihood estimator's gain over the standard instrumental variable estimator is that the empirical distribution of (Y, A, R) might not satisfy the restrictions given by Assumptions 1-6. The approximate maximum empirical likelihood estimator takes these restrictions into account to provide a better estimate of the distribution of (Y, A, R) than the empirical distribution. However, unless the distribution of (Y, A, R) is 'at the boundary' of the restrictions given by Assumptions 1-6, the empirical distribution of (Y, A, R) should satisfy the restrictions with probability converging to 1 as the sample size N → ∞. Consequently, the approximate maximum empirical likelihood estimator will be asymptotically equivalent to the standard instrumental variable estimator. We establish this result in Theorem 1 under condition (11) below. Condition (11) specifies that the distribution of (Y, A, R) is not 'at the boundary' of the restriction that the Y | R = 0 is a mixture of the compliers and never-takers under the control in the sense that the distributions of the compliers and never-takers under the control overlap at least minimally. In condition (11), we let F c0 and F n0 denote the cumulative distribution functions of potential outcomes under the control for compliers and never-takers, respectively, and we let G = π c F c0 + (1 − π c )F n0 denote the cumulative distribution function of potential outcomes under the control,
Condition (11) says that the trimmed mean of the π n -smallest part of the mixture of never-takers and compliers is strictly less than the mean of the never-takers and that the trimmed mean of the π n -largest part of the mixture of never-takers and compliers is strictly greater than the mean of the never-takers. Under condition (11), we have THEOREM 1. Consider a single consent design. Suppose (i) (11) holds, (ii) 0 < π c < 1 and
The proof of Theorem 1 is in Appendix B.
In spite of the asymptotic equivalence result in Theorem 1, the simulation study in § 4 showed that the approximate maximum empirical likelihood estimator can provide substantial gains in practical situations. The gains provided by the approximate maximum empirical likelihood estimator are analogous to the gains provided in estimating a population mean provided by knowledge of restrictions on the range of the mean. For example, consider estimating the mean μ of a normal distribution N (μ, σ 2 ) based on a random sample Y 1 , . . . , Y N when it is known that μ is less than or equal to an upper bound μ U . If μ is reasonably close to μ U , then the maximum likelihood estimate will gain substantially over the sample mean, the maximum likelihood estimate if μ is unrestricted, for many sample sizes. However, as long as μ is less than μ U by any amount, the estimators are equivalent asymptotically because, for large enough N , the sample mean is less than μ U with high probability.
APPLICATION TO DEPRESSION STUDY
In this section, we apply our method to analyze a randomized trial of an intervention to improve treatment of depression among depressed elderly patients in primary care practices (Bruce et al., 2004) . The encouragement intervention was that a depression care specialist collaborated with the patient's primary care physician to facilitate adherence to a depression treatment strategy and provide education and assessment to the patient. The control was usual care. The study involved 539 depressed patients in 20 primary care practices at three sites followed for six visits: baseline, 4, 8, 12, 18 and 24 months. Each practice was randomized to either intervention, the treatment, or usual care, the control. For illustrative purposes, we ignore the fact that the trial was a group randomized trial and treat it as a completely randomized trial; for analyses that account for the group randomization, see Small et al. (2008) . Compliance with the intervention was categorized as a binary variable, whether or not a patient had seen a depression care specialist in the prior four months of follow-up. Patients in practices randomized to the usual-care group did not have access to the depression specialist, so there are only compliers and never-takers in this trial. To see the effects of estimators under different situations, we analyze two outcomes. One is the patients' Hamilton depression scores measured at 4 months, which take integer values between 0 and 50. A lower value of the outcome means less depression. Another outcome of analysis is the composite antidepression scores among males at one site measured at 12 months. This is an integer-valued score from 0 to 4 that indicates how much the patient is being treated for depression. A score of 3 or 4 is considered adequate treatment for depression while 1 or 2 means the patient is being treated in some way, but not adequately. Table 5 shows the three estimates of the complier average causal effect for the Hamilton and composite antidepression scores described above. The percentile bootstrap with 1000 resamples was used to compute approximate 95% confidence intervals. We first consider the Hamilton score at 4 months; see the second column of Table 5 . The scores were observed for 517 subjects and 92·7% of these subjects that were assigned to treatment complied with the treatment. All the complier average causal effect estimates are negative and the 95% confidence intervals do not include zero, indicating that the intervention has a significant beneficial effect on depression compared to usual care. Comparing the three estimation methods, we first note from the histograms of the Hamilton outcome in Fig. 2(a) -(c) that the Hamilton scores for the never-takers and compliers under the treatment and control are far from normally distributed, suggesting that the parametric estimator based on the normality assumption is probably a biased estimator. The standard instrumental variable estimator and the approximate maximum empirical likelihood estimator provide very similar point estimates and similar 95% confidence intervals; see below for more explanation of this similarity. We now consider the outcome of the composite antidepression scores among males at the site at 12 months, given in the third column of Table 5 . The scores were observed for 37 subjects and 75% of these subjects who were assigned to treatment complied with the treatment. The approximate maximum empirical likelihood and standard instrumental variable complier average causal effect estimates show a significant beneficial effect of the intervention on treating depression while the parametric normal estimate does not show a significant effect. As for the Hamilton score, the histograms of the composite antidepression outcomes in Fig. 2(d)-(f) show that the composite antidepression scores from the never-takers and compliers under the treatment and control are far from normally distributed, suggesting that the parametric estimator based on the normality assumption is a biased estimator. Unlike for the Hamilton score, for the complier average causal effect of the intervention on the composite antidepression score, the approximate maximum empirical likelihood estimate has a substantially narrower 95% confidence interval than the standard instrumental variable estimate.
The greater gain in efficiency of the approximate maximum empirical likelihood estimate compared to standard instrumental variable estimate for the composite antidepression study in relation to the Hamilton study is related to three factors. First, the sample size in the R = 0 group is smaller for the composite antidepression study, making it more likely that the empirical distribution of (Y, A, R) will deviate from the restrictions implied by Assumptions 1-6. Second, the compliance rate among the subjects assigned to treatment is higher for the Hamilton study, 93%, than the composite antidepression study, 75%, providing less scope in the Hamilton study for the extra information about Assumptions 1-6 used by the approximate maximum empirical likelihood estimator to have an impact. Third, the separation between the never-takers' and compliers' outcome distributions in the control group is greater for the composite antidepression than for the Hamilton; if we use the estimates of μ n and μ c0 obtained by substituting method of moments estimates into the population expressions for these quantities in (3), the estimated absolute standardized difference between the never-takers' and compliers' means in the control group is 2·34 for the composite antidepression compared to 0·72 for the Hamilton. As we have shown in our simulation studies, the approximate maximum empirical likelihood estimator will have a larger gain in efficiency over the standard instrumental variable estimator when the distributions of the never-takers and compliers in the control group are more separated.
DISCUSSION
Our method can be extended to observational studies in which a variable R, which encourages, R = 1, or does not encourage, R = 0, a subject to take the treatment is not randomly assigned but is 'as good as randomly assigned', that is, ignorable, conditional on some covariates; such studies are discussed in Abadie (2003) and examples are given in Table 1 of Angrist & Krueger (2001) . Suppose we replace Assumption 2 with Assumption 2 that the encouragment variable R is independent of Y 1,1 , Y 1,0 , Y 0,1 , Y 0,0 , A 0 , A 1 conditional on a subject's covariate vector X and that the encouragement variables of different subjects are independent. Also, suppose we expand Assumption 3 to Assumption 3 that X i , Y i are independent and identically distributed draws from a superpopulation and expand Assumption 4 to condition on covariates, i.e., let Assumption 4 be that E(Y r,a | X ) = E(Y r ,a | X ) for all r, r , a, X . Furthermore, for a single consent design, suppose we consider linear models for the expected potential outcomes in a compliance class given the covariates and a logistic model for compliance given the covariates, i.e., E(Y 1,1 | C = 1, X ) = X β c1 , E(Y 0,0 | C = 1, X ) = X β c0 , E(Y 1,0 | C = 0, X ) = E(Y 0,0 | C = 0, X ) = X β n and pr(C = 1 | X ) = expit(X α), where expit(z) = e z /(1 + e z ). We include an intercept in the covariate vector X and let p denote the dimension of X . Under this model, the complier average causal effect for compliers with covariate vector X is X β c1 − X β c0 . Under Assumptions 1, 2 , 3 , 4 , 5 and 6 and the above models for the outcomes and compliance probabilities, we have that the empirical likelihood of α, β c1 , β c0 and β n is L E (α, β n , β c1 , β c0 ) = max q 1 ,...,q N N i=1 q i subject to (i) = 1, . . . , p) . Here the t c0 i , t n i , respectively represent the population probabilities that a subject assigned to the control has the same outcome and covariates as subject i and is a complier, never-taker, respectively. The above expression for the empirical likelihood builds on Owen's (2001, chap. 4 ) discussion of empirical likelihood for regression models. As in our method of § 3, we can compute the approximate maximum empirical likelihood estimate by estimating β n using the R = 1, A = 0 sample and maximizing the empirical likelihood over α, β c1 and β c0 given β n =β n .
When deriving the approximate maximum empirical likelihood estimator, we have assumed the weak exclusion restriction that the never-takers', always-takers', respectively, mean is the same under assignment to treatment and control, rather than the strong exclusion restriction that the never-takers', always-takers', respectively entire outcome distribution is the same under assignment to treatment and control. In most situations in which the weak exclusion restriction is plausible, we think that the strong exclusion restriction will also be plausible. We are currently adapting our approach to situations in which the strong exclusion restriction is plausible by enabling the empirical likelihood approach to use more equality constraints for aspects of the never-takers and always-takers under R = 0 and R = 1 distributions, respectively, than just equality of means.
